Caliway's CBL-514 Combination Therapy Cleared by U.S. FDA for Phase 2 Trial; Pivotal Phase 3 Trial SUPREME-01 Initiates Enrollment FDA IND Clearance for CBL-0201WR—Caliway has cleared its Investigational New Drug application… August 26, 2026
Founder Securities Chief Economist Yan Xiang: China's Capital Market Is Better Aligned and More Effective in Backing the New Growth Drivers BEIJING, Aug. 26, 2026 /PRNewswire/ — The Political Bureau of the CPC… August 26, 2026
Agoda and NTT DATA Advance Renewable Energy and Data Center Efficiency in Singapore SINGAPORE, Aug. 26, 2026 /PRNewswire/ — Digital travel platform Agoda today announced… August 26, 2026
Joyson Electronics Announces H1 2026 Results: Net Profit Attributable to Shareholders of RMB 740 Million Accelerating Breakthroughs in Emerging Technology Business HONG KONG, Aug. 25, 2026 /PRNewswire/… August 26, 2026
Gen Precision Launches Automated DIMM Final Test System GTK-SPT1 for Unattended DRAM Module Testing Gen Precision’s GTK-SPT1 automates DDR4 and DDR5 DIMM final testing and burn-in,… August 26, 2026
Handshakes Launches AI Agent to Transform Corporate Due Diligence and Investigation Drawing on decades of regulatory expertise, the beta AI-powered agent runs due… August 26, 2026
HaemaLogiX Announces Major Milestone with First Patient Successfully Dosed with KMCAR™ T-Cell KEY POINTS First patient safely dosed in Phase 1 KOALA trial evaluating… August 26, 2026
Symbos Receives Frost & Sullivan's 2026 Australian Transformational Innovation Leadership Recognition for its Customer Experience Management Services The company is setting a new benchmark in Australian CXM through outcome-focused… August 26, 2026
